PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 1 month ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 2 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 1 year 4 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 1 year 4 months ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 4 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
BRIEF published on 09/12/2024 at 07:35, 1 year 4 months ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
Published on 01/29/2026 at 03:30, 5 hours 2 minutes ago NuRAN Provides Clarification and Corrections Regarding Restructuring Transaction Disclosure
Published on 01/29/2026 at 02:15, 6 hours 17 minutes ago McEwen Inc. to Acquire Golden Lake Exploration Inc.
Published on 01/29/2026 at 01:50, 6 hours 42 minutes ago Alphinat Announces a Net Profit of $89,282 for Quarter Ended November 30, 2025
Published on 01/29/2026 at 00:00, 8 hours 32 minutes ago Tokenwell Adds Single-Coin Trading Capabilities and Expands Exchange Support
Published on 01/28/2026 at 23:45, 8 hours 47 minutes ago CoTec Holdings Corp. Announces Warrant Exercise by Kings Chapel
Published on 01/29/2026 at 08:20, 12 minutes ago Innovative and Immersive, ISLE 2026 to Define the Future of Display and Integration
Published on 01/29/2026 at 08:05, 27 minutes ago Roma Embassy in The Hague officially established for diplomatic relations
Published on 01/29/2026 at 07:30, 1 hour 2 minutes ago Steyr Motors receives development contract from a leading international defense and technology group based in Singapore
Published on 01/28/2026 at 18:00, 14 hours 32 minutes ago Launch of Skira Education Systems and acquisition of Institut Beau Cèdre
Published on 01/28/2026 at 17:45, 14 hours 47 minutes ago Infotel : Q4 2025 revenue up +3.5%. Acquisition of Sesin, a specialist in EDM. A promising start to 2026
Published on 01/28/2026 at 17:40, 14 hours 52 minutes ago Mersen: Sales of €1.2 billion in 2025, in line with expectations
